Health care companies are bracing for headwinds as drug pricing provisions of the #Inflation Reduction Act go into effect. Johnson & Johnson CFO Joe Wolk says that will weigh on innovation across the industry. Watch the full episode of Bloomberg Chief Future Officer: https://youtu.be/DbVk5oO1f4s
